CD4+ Th2 Cell Recognition of HLA-DR-Restricted Epitopes Derived from CAMEL: A Tumor Antigen Translated in an Alternative Open Reading Frame von Slager, Elisabeth H, Borghi, Martina, van der Minne, Carolien E, Aarnoudse, Corlien A, Havenga, Menzo J. E, Schrier, Peter I, Osanto, Susanne, Griffioen, Marieke

Volltext

Abstract CT194: Low-dose Interferon-alpha pre-conditioning and adoptive cell therapy in metastatic melanoma patients refractory to standard (immune) therapies - a phase 1/2 study von van der Kooij, Monique K., Verdegaal, Els M., Visser, Marten, van der Minne, Carolien E., de Bruin, Linda, Meij, Pauline, van Scheltinga, Anton G. Terwisscha, Welters, Marij J., Santegoets, Saskia J., de Miranda, Noel F., Roozen, Inge C., Liefers, Gerrit-Jan, Kapiteijn, Ellen, van der Burg, Sjoerd H.

Volltext

Peptide‐pulsed dendritic cells induce tumoricidal cytotoxic T lymphocytes from healthy donors against stably HLA‐A0201‐binding peptides from the Melan‐A/MART‐1 self antigen... von van Elsas, Andrea, van der Burg, Sjoerd H., van der Minne, Carolien E., Borghi, Martina, Mourer, Jacqueline S., Melief, Cornelis J. M., Schrier, Peter I.

Volltext

Transfection of IL-2 augments CTL response to human melanoma cells in vitro: immunological characterization of a melanoma vaccine von van Elsas, A, Aarnoudse, C, van der Minne, C E, van der Spek, C W, Brouwenstijn, N, Osanto, S, Schrier, P I

Volltext